We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Industry

Image: The Colox test kit for the detection of colorectal cancer (Photo courtesy of Diagnoplex SA).

Blood-Based Molecular Test Improves Early Detection of Colorectal Cancer

A convenient blood test can be ordered by a physician during a routine medical checkup to accurately and reliably detect both adenomatous polyps and early stages of colorectal cancer.  More...
03 Mar 2015
Image: DiaDome target groups (Photo courtesy of DiaDome).

Social Network for Diagnostics Launched

A social network is specifically designed for business interaction in field of diagnostics has been started.  More...
01 Mar 2015
Image: Under a new partnership for liquid handling measurement automation, Artel will provide STRATEC’s innovative “Tholos” technology, which measures liquid and solid contents of 96- and 384-well microplates, under the name Artel “SDS” - Sample Detection System (Photo courtesy of Artel).

Artel Expands Portfolio with STRATEC Partnership for Automation Technology

Artel, a leader in laboratory liquid handling measurement systems, and STRATEC Biomedical, a leader in automated systems for clinical diagnostics and biotechnology, have entered into a strategic partnership for STRATEC’s innovative “Tholos” technology, which measures liquid and solid contents of 96- and 384-well microplates.   More...
16 Feb 2015

After First Approval of a Rapid Molecular Test, Expect More

According to Kalorama Information, the first CLIA-waiver approval for broad use of a rapid molecular diagnostic test for influenza, from Alere, demonstrates the potential for the molecular point-of-care sector predicted in Kalorama’s 2014 report.    More...
15 Feb 2015

Collaboration Agreement Targets Tumor-Related Genes

A German biomedical company has entered into a collaborative agreement with a major Norwegian hospital that focuses on the identification of cancer-related tumor genes that predict a patient’s response or resistance to targeted therapies.  More...
02 Feb 2015

Emerging Products Provide Opportunity in Prenatal Diagnostics

The recent increase in opportunity has been revealed in the latest study of women’s health diagnostics by Kalorama Information’s, which has reported extensively on prenatal testing markets for over a decade.   More...
01 Feb 2015
Image: Positive case of lung tissue stained for ALK with VENTANA ALK (D5F3) CDx Assay, a companion diagnostic immunohistochemical test in the final stages of the FDA premarket approval process (Photo courtesy of Ventana Medical Systems and PRNewsFoto).

Premarket Approval Sought for CDx Test to Benefit Lung Cancer Patients

Ventana Medical Systems has announced its US FDA final-stage submission for premarket approval of its companion diagnostic immunohistochemistry test designed to identify ALK1-positive lung cancer patients that may benefit from treatment with targeted therapy that inhibits the ALK gene.   More...
25 Jan 2015
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
New
Clinical Chemistry System
P780
New
Urine Chemistry Control
Dropper Urine Chemistry Control


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2025 Globetech Media. All rights reserved.